The South Carolina Department of Health and Environmental Control released the state’s latest coronavirus numbers as of Sunday.
A health expert says one of the COVID-19 variants spreading through parts of the country has him re-evaluating his own advice on sending kids back to school.
The Richland County Library is hosting a COVID-19 Caccine Tele-Town Hall Monday night. From 6:30-7:30 p.m., South Carolina Department of Health and Environmental Control Assistant State Epidemiologist Dr. Jane Kelly will talk about the three vaccines now available, the safety and efficacy of each one, and she will also take questions from you about the vaccines.
If you’re getting ready for a little time with family and friends this Easter weekend, the Centers for Disease Control and Prevention says to be cautious if not everyone is vaccinated. Health experts say it’s too soon to let your guard down, especially as COVID-19 variants continue to spread.
Good news for your kids who want to get vaccinated as well, Johnson & Johnson says it is testing its single-dose COVID-19 vaccine in teens. The company will start by adding 16 and 17-year-olds to its phase 2a trials, which have been ongoing since September.
The South Carolina Department of Health and Environmental Control says the transition into phase 1c this week is going smoothly, and they owe it all to their vaccine providers. South Carolina is now ranked in the top tier nationally by the CDC for the amount of doses administered in the country.
The Centers for Disease Control and Prevention says if you have had your COVID-19 shots, you can travel with less worry. Friday, the agency updated its guidance for travel for people who have been fully vaccinated.
The South Carolina Department of Health and Environmental Control released the stat’s latest coronavirus numbers as of Thursday.
Pfizer says new trial data is giving a glimpse into how long its vaccine protection lasts, and how effective it is against one variant.
Pfizer says protection from its COVID-19 vaccine lasts at least six months after the second dose. The pharmaceutical company has been studying the vaccine in nearly 5,000 volunteers. Among that group, 77 people who were vaccinated tested positive for COVID-19.
